前列腺癌放疗后患者报告结局:预测工具准确性与验证的系统综述
该系统综述检索了2007年7月以来的PubMed和EMBASE数据库,最终纳入22项研究,评估用于预测前列腺癌放疗患者报告结局的验证工具。研究发现大量预测工具被开发,但仅少数工具准确性≥70%且经外部验证可推荐临床使用。
要点
- 50个工具预测胃肠/直肠症状,29个预测泌尿生殖症状,4个预测勃起功能障碍,无工具预测生活质量。
- 外照射放疗中,3个工具可推荐用于预测直肠毒性、胃肠毒性和勃起功能障碍。
- 近距离放疗中,2个工具可推荐用于预测尿潴留和勃起功能障碍。
核心结论
- 前列腺癌放疗患者报告结局预测工具大量开发,但仅少数准确且经外部验证可推广。
- 本综述提供了可临床实施的工具目录及需优先验证的工具清单。
研究设计与样本
- 系统综述,检索PubMed和EMBASE自2007年7月起的文献。
- 两名评价者进行标题/摘要筛选、全文审查和批判性评估,单名评价者提取数据。
- 纳入标准为提供准确性汇总指标并进行内部或外部验证的研究。
主要发现
- 检索识别3839项潜在研究,236项进入全文审查,最终纳入22项。
- 纳入研究中,50个工具预测胃肠/直肠症状,29个预测泌尿生殖症状,4个预测勃起功能障碍,无工具预测生活质量。
- 外照射放疗中,3个工具可推荐用于预测直肠毒性、胃肠毒性和勃起功能障碍。
- 近距离放疗中,2个工具可推荐用于预测尿潴留和勃起功能障碍。
关键数值与推荐
- 工具推荐临床实施的标准为:经外部验证且准确性≥70%。
临床怎么用
- 临床可参考本综述目录选择经外部验证且准确性≥70%的工具用于预测前列腺癌放疗患者报告结局。
- 对尚未经外部验证的工具应优先开展验证研究。
局限性
- 数据提取由单名评价者完成。
- 仅纳入提供准确性汇总指标并进行验证的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify, through a systematic review, all validated tools used for the prediction of patient-reported outcome measures (PROMs) in patients being treated with radiation therapy for prostate cancer, and provide a comparative summary of accuracy and generalizability. METHODS AND MATERIALS: PubMed and EMBASE were searched from July 2007. Title/abstract screening, full text review, and critical appraisal were undertaken by 2 reviewers, whereas data extraction was performed by a single reviewer. Eligible articles had to provide a summary measure of accuracy and undertake internal or external validation. Tools were recommended for clinical implementation if they had been externally validated and found to have accuracy ≥70%. RESULTS: The search strategy identified 3839 potential studies, of which 236 progressed to full text review and 22 were included. From these studies, 50 tools predicted gastrointestinal/rectal symptoms, 29 tools predicted genitourinary symptoms, 4 tools predicted erectile dysfunction, and no tools predicted quality of life. For patients treated with external beam radiation therapy, 3 tools could be recommended for the prediction of rectal toxicity, gastrointestinal toxicity, and erectile dysfunction. For patients treated with brachytherapy, 2 tools could be recommended for the prediction of urinary retention and erectile dysfunction. CONCLUSIONS: A large number of tools for the prediction of PROMs in prostate cancer patients treated with radiation therapy have been developed. Only a small minority are accurate and have been shown to be generalizable through external validation. This review provides an accessible catalogue of tools that are ready for clinical implementation as well as which should be prioritized for validation.
引用
- O'Callaghan ME, Raymond E, Campbell JM, et al. Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463151. doi:10.1016/j.ijrobp.2017.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。